Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-024352

OPKO HEALTH, INC. · OPK

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Phillip Md Et Al Frost
Officer — CEO & Chairman · Director · 10% Owner
Period of report
Apr 3, 2017
Accepted (ET)
Apr 4, 2017 · 7:36 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000944809

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Apr 3, 2017P200$7.745A160,810,543ISee Footnote
Common StockF1Apr 3, 2017P3,400$7.75A160,813,943ISee Footnote
Common StockF1Apr 3, 2017P3,600$7.77A160,817,543ISee Footnote
Common StockF1Apr 3, 2017P400$7.795A160,817,943ISee Footnote
Common StockF1Apr 3, 2017P2,900$7.80A160,820,843ISee Footnote
Common StockF1Apr 3, 2017P300$7.81A160,821,143ISee Footnote
Common StockF1Apr 3, 2017P3,600$7.82A160,824,743ISee Footnote
Common StockF1Apr 3, 2017P3,200$7.83A160,827,943ISee Footnote
Common StockF1Apr 3, 2017P100$7.835A160,828,043ISee Footnote
Common StockF1Apr 3, 2017P300$7.84A160,828,343ISee Footnote
Common StockF1Apr 3, 2017P900$7.89A160,829,243ISee Footnote
Common StockF1Apr 3, 2017P900$7.90A160,830,143ISee Footnote
Common StockF1Apr 3, 2017P1,710$8.00A160,831,853ISee Footnote
Common StockF1Apr 3, 2017P90$8.02A160,831,943ISee Footnote
Common Stockholding———3,068,951D
Common StockF2holding———20,091,062ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses